OTLK
Outlook Therapeutics·NASDAQ
--
--(--)
--
--(--)
OTLK fundamentals
Outlook Therapeutics (OTLK) released its earnings on Dec 19, 2025: revenue was -100.00K (YoY --), missed estimates; EPS was -0.06 (YoY +93.18%), beat estimates.
Revenue / YoY
-100.00K
--
EPS / YoY
-0.06
+93.18%
Report date
Dec 19, 2025
EPS
Actual | -2.6 | -0.6 | 1 | -2.2 | -1.8 | -1.4 | -1.6 | -1.6 | -1.8 | -1.6 | -1.2 | -1.6 | -0.6 | -1.6 | -1 | -0.8 | -1.55 | -0.83 | -0.88 | -0.89 | -0.4 | -0.44 | -0.06 | |||||||
Forecast | -2.88 | -1.9 | -1.88 | -1.6 | -1.9333 | -1.4 | -1.2667 | -1.2 | -1.2 | -1.4667 | -1.3272 | -1.19 | -1.2814 | -1.05 | -1.15 | -0.9946 | -0.9099 | -1.0329 | -0.8033 | -0.76 | -0.5428 | -0.3525 | -0.26 | |||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +9.72% | +68.42% | +153.19% | -37.50% | +6.89% | 0.00% | -26.31% | -33.33% | -50.00% | -9.09% | +9.58% | -34.45% | +53.18% | -52.38% | +13.04% | +19.57% | -70.35% | +19.64% | -9.55% | -17.11% | +26.31% | -24.82% | +76.92% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.50M | -100.00K |
Forecast | -- | -- | -- | -- | -- | -- | -- | 162.50K | 216.67K | 162.50K | 0 | 325.00K | 325.00K | 300.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.49M | 0 | 0 | 0 | 0 | 0 | 628.25K | 1.50M | 5.84M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -100.00% | -100.00% | 0.00% | -100.00% | -100.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | +0.33% | -101.71% |
Earnings Call
You can ask Aime
What were the key takeaways from Outlook Therapeutics's earnings call?Did Outlook Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Outlook Therapeutics year over year?What factors drove the changes in Outlook Therapeutics's revenue and profit?What is the market's earnings forecast for Outlook Therapeutics next quarter?What were the key takeaways from Outlook Therapeutics’s earnings call?What does Outlook Therapeutics do and what are its main business segments?What guidance did Outlook Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
